Skip to main content
Equibles

D. E. Shaw & Co., Inc.

Position in ZTS — Zoetis Inc.

CIK 1009207 New York, NY
Back to ZTS Full portfolio

Position in ZTS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$38,625,827
+$29,742,465 QoQ
Shares Held
537,515
+615.3% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#104
of 1,408 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in ZTS Over Time

Shares Held

Position Value (USD)

Derivatives in ZTS

reported options exposure · as of Jun 30, 2026
CallValue
$280,254
CallShares
3,900
PutValue
$4,584,668
PutShares
63,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $657,589,731 across 42 Drug Manufacturers - Specialty & Generic names. ZTS ranks #5 (5.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LQDA
Liquidia Corp
 1,267,706 $101,074,198
2 ALKS
Alkermes plc.
 1,312,031 $68,750,423
3 XERS
Xeris Biopharma Holdings, Inc.
 7,804,758 $61,813,683
4 PCRX
Pacira BioSciences, Inc.
 1,950,332 $49,479,922
5 ZTS
Zoetis Inc.
This page 		537,515 $38,625,827
6 KNSA
Kiniksa Pharmaceuticals International, plc
 569,756 $36,435,896
7 SUPN
Supernus Pharmaceuticals, Inc.
 767,668 $35,704,237
8 TAK
Takeda Pharmaceutical Co Ltd
 2,049,467 $32,852,956

All Filings in ZTS

Export CSV
44 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,584,668 63,800
2026-06-30 $280,254 3,900
2026-06-30 $38,625,827 537,515
2026-03-31 $248,241 2,100
2026-03-31 $8,883,362 75,149
2025-12-31 $264,222 2,100
2025-12-31 $152,839,466 1,214,747
2025-09-30 $233,754,101 1,597,554
2025-09-30 $1,258,352 8,600
2025-06-30 $119,714,081 767,644
2025-03-31 $54,543,440 331,269
2024-12-31 $1,629,300 10,000
2024-12-31 $47,037,075 288,695
2024-09-30 $2,305,484 11,800
2024-09-30 $13,288,183 68,012
2024-06-30 $12,140,746 70,032
2024-06-30 $2,045,648 11,800
2024-03-31 $238,681,703 1,410,565
2023-12-31 $1,429,550 7,243
2023-03-31 $2,277,398 13,683
2022-12-31 $30,691,379 209,426
2022-09-30 $120,824,912 814,788
2022-06-30 $172,950,904 1,006,172
2022-03-31 $67,553,126 358,201
2021-12-31 $12,448,946 51,014
2021-12-31 $2,440,300 10,000
2021-09-30 $1,941,400 10,000
2021-09-30 $31,194,414 160,680
2021-06-30 $1,863,600 10,000
2021-06-30 $133,307,594 715,323
2021-03-31 $378,635,305 2,404,339
2021-03-31 $1,574,800 10,000
2020-12-31 $4,965,000 30,000
2020-12-31 $249,018,085 1,504,641
2020-12-31 $2,432,850 14,700
2020-09-30 $2,430,939 14,700
2020-09-30 $4,961,100 30,000
2020-09-30 $104,974,063 634,783
2020-06-30 $4,111,200 30,000
2020-06-30 $2,014,488 14,700
2020-06-30 $67,219,079 490,507
2020-03-31 $28,935,262 245,860
2020-03-31 $1,730,043 14,700
2020-03-31 $2,353,800 20,000

Report a Problem

Category
Description
Email (optional, for follow-up)